An Open Label Study to Assess the Safety, Tolerability and Efficacy of Frovatriptan in the Prevention of Menstrually Associated Migraine (MAM) Headaches.

Trial Profile

An Open Label Study to Assess the Safety, Tolerability and Efficacy of Frovatriptan in the Prevention of Menstrually Associated Migraine (MAM) Headaches.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Dec 2009

At a glance

  • Drugs Frovatriptan (Primary)
  • Indications Menstrual migraine
  • Focus Adverse reactions
  • Sponsors Endo Pharmaceuticals
  • Most Recent Events

    • 25 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top